Literature DB >> 20408961

Phenotypic patterns of MELAS/LS overlap syndrome associated with m.13513G>A mutation, and neuropathological findings in one autopsy case.

Zhaoxia Wang1, Xiao Kun Qi, Sheng Yao, Bin Chen, Xinghua Luan, Wei Zhang, Manfu Han, Yun Yuan.   

Abstract

The 13513G>A mutation in the ND5 gene of mitochondrial DNA (mtDNA) is usually associated with mitochondrial encephalomyopathy with lactate acidosis and stroke-like episodes (MELAS), or Leigh syndrome (LS). In this study, we describe three young Chinese patients with MELAS/LS overlap syndrome who carried the m.13513G>A mutation. Clinical and MRI features were characteristic of both MELAS and LS. Interestingly, the clinical presentation of this overlap syndrome could be variable depending on the degree of relative contribution of MELAS and LS, that is, MELAS as the initial presenting syndrome, LS as the predominant syndrome, or both MELAS and LS appearing at the same time. The final brain MRI showed findings characteristic of both MELAS and LS, with asymmetrical lesions in the cortex and subcortical white matter of the occipital, temporal, and frontal lobes (MELAS), and bilateral and symmetrical lesions in the basal ganglia and brainstem (LS). Brain autopsy in one case revealed infarct-like lesions in the cerebral cortex, basal ganglia and brainstem, providing further insight into the distribution of the pathological lesions in MELAS/LS overlap syndrome. This is the first report of the brain pathological changes in a patient with m.13513G>A mutation. The spatial distribution of infarct-like lesions in the brain could explain the symptoms in MELAS/LS overlap syndrome.
© 2010 Japanese Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408961     DOI: 10.1111/j.1440-1789.2010.01115.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  8 in total

1.  Mitochondrial m.13513G>A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing.

Authors:  Daniel Vázquez-Justes; Lidia Carreño-Gago; Elena García-Arumi; Alicia Traveset; Julio Montoya; Eduardo Ruiz-Pesini; Ricard López; Luis Brieva
Journal:  J Pediatr Genet       Date:  2019-05-28

2.  Current proceedings of childhood stroke.

Authors:  Hueng-Chuen Fan; Chih-Fen Hu; Chun-Jung Juan; Shyi-Jou Chen
Journal:  Stroke Res Treat       Date:  2011-02-07

3.  Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant.

Authors:  Valentina Barone; Chiara La Morgia; Leonardo Caporali; Claudio Fiorini; Michele Carbonelli; Laura Ludovica Gramegna; Fiorina Bartiromo; Caterina Tonon; Luca Morandi; Rocco Liguori; Aurelia Petrini; Rachele Brugnano; Rachele Del Sordo; Carla Covarelli; Manrico Morroni; Raffaele Lodi; Valerio Carelli
Journal:  Front Genet       Date:  2022-06-03       Impact factor: 4.772

4.  Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes/Leigh Overlap Syndrome Due to Variant m.13513G>A in MT-ND5.

Authors:  Josef Finsterer; John Hayman
Journal:  Cureus       Date:  2022-05-05

5.  MELAS with multiple stroke-like episodes due to the variant m.13513G>A in MT-ND5.

Authors:  Ritwik Ghosh; Souvik Dubey; Subhas Bhuin; Durjoy Lahiri; Biman Kanti Ray; Josef Finsterer
Journal:  Clin Case Rep       Date:  2022-02-02

6.  Leigh Syndrome in Childhood: Neurologic Progression and Functional Outcome.

Authors:  Jin Sook Lee; Hunmin Kim; Byung Chan Lim; Hee Hwang; Jieun Choi; Ki Joong Kim; Yong Seung Hwang; Jong Hee Chae
Journal:  J Clin Neurol       Date:  2016-04       Impact factor: 3.077

7.  Perioperative risk assessment for successful kidney transplant in leigh syndrome: a case report.

Authors:  Kathryn Ducharlet; Dominic Thyagarajan; Francesco Ierino; Lawrence P McMahon; Darren Lee
Journal:  BMC Nephrol       Date:  2018-02-01       Impact factor: 2.388

Review 8.  Mitochondrial diseases caused by mtDNA mutations: a mini-review.

Authors:  Anastasia I Ryzhkova; Margarita A Sazonova; Vasily V Sinyov; Elena V Galitsyna; Mariya M Chicheva; Alexandra A Melnichenko; Andrey V Grechko; Anton Yu Postnov; Alexander N Orekhov; Tatiana P Shkurat
Journal:  Ther Clin Risk Manag       Date:  2018-10-09       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.